[Federal Register Volume 62, Number 152 (Thursday, August 7, 1997)]
[Notices]
[Page 42587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-20864]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the following National Heart, Lung, and Blood Institute Special 
Emphasis Panel.
    The meeting will be open to the public to provide concept review of 
proposed contract or grant solicitations.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
inform the Contact Person listed below in advance of the meeting.

    Name of Panel: Clinical Trials in Diabetes and CVD.
    Date: September 19, 1997.
    Time: 8:00 a.m.
    Place: NIH Main Campus, 31 Center Drive, Building 31, 6th Floor, 
C Wing, Conference Room 7.
    Agenda: To consider the need for a clinical trial to determine 
optimal intervention strategies to prevent or reduce CVD in diabetic 
patients.

    Contact Persons:
Peter Savage, M.D., Deputy Director, DECA, II Rockledge Center, 6701 
Rockledge Drive, MSC 7938, Room 8104, Bethesda, Maryland 20892-7938, 
(301) 435-0422.
George Sopko, M.D., Medical Officer, DHVD, II Rockledge Center, 6701 
Rockledge Drive, MSC 7940, Room 9176, Bethesda, MD 20892-7940, (301) 
435-0515.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health.)

    Dated: July 31, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-20864 Filed 8-6-97; 8:45 am]
BILLING CODE 4140-01-M